I think we can be assured that TIS and subsquently BSI has submitted a response as Vitrogro is listed opinion for adoption in CHMP' February meeting.
EMA will have made up their mind one way or another by the end of March if its a green light or not.
Given its listed as for adoption in the Feburary meeting (23rd - 26th Feb) who knows they may have made their minds up by the end of this week and may get an announcement apout approval early next.
Link follows for Feb meeting schedule Vitrogro is mentioned at
5. Ancillary medicinal substances in medical devices ................................ 17
http://www.ema.europa.eu/docs/en_GB/document_library/Agenda/2015/02/WC500183118.pdf